Trident® II 3D - South Tees

  • Research type

    Research Study

  • Full title

    Performance and Function of the Trident® II 3D printed Acetabular Component

  • IRAS ID

    276445

  • Contact name

    Simon Jameson

  • Contact email

    simonjameson@nhs.net

  • Sponsor organisation

    South Tees Hospitals NHS Foundation Trust

  • ISRCTN Number

    ISRCTN57876689

  • Duration of Study in the UK

    12 years, 0 months, 1 days

  • Research summary

    This is a post-market clinical, prospective single centre cohort study of a CE marked device. The hip is a ball and socket joint. In a total hip arthroplasty (THA), both the ball and the socket will be replaced. Trident II is a new component that will be used to replace the socket of the hip, in a THA. Participants in this study will be amongst the first to be receiving the Trident II component as part of their routine care. Therefore, it is important to find out how the hip performs and how well patients are performing after a THA. \n\nPatients meeting the criteria for the study will be asked to enroll, targeting males and non-pregnant females between 40 and 75 years of age, a BMI < 40, requiring uncemented primary THA as a result of osteoarthritis (OA), avascular necrosis (AVN) or post-traumatic arthritis (TA). This new component aims to offer patients a better range of movement, lower the risk of dislocation and a more stable joint.\n \nThe patients will be monitored clinically by follow-up examinations, radiographs and patient reported outcome questionnaires (Oxford Hip Score (OHS), Forgotten Joint Score (FJS), EQ5D-5L). OHS assesses symptoms and functional limitations related to the hip. The FJS is a tool to assess patient’s awareness of their artificial joint in everyday life. EQ5D-5L is a standardised instrument for use as a measure of health outcome and quality of life.\n\nThe length of the study follow-up schedule is not current local standard practice following THA due to constraints related to CCG funding. However, this study will implement a pragmatic, long-term post-operative follow-up based on the BOA standards for introducing new implants as per the study evaluation schedule. While long-term data will be collected, the radiographic requirements for the study will not exceed the national recommendations of the BOA.

  • REC name

    South West - Central Bristol Research Ethics Committee

  • REC reference

    22/SW/0024

  • Date of REC Opinion

    15 Mar 2022

  • REC opinion

    Further Information Favourable Opinion